glp-1 lawsuit news today 2025 Ozempic [July 2026 Update] Novo Nordisk expands legal action

Trials have demonstrated reductions in major adverse cardiovascular events along with significant weight reduction, particularly with agents such as semaglutide and dulaglutide

Many GLP-1 users need the higher end of supplementation

2025 [cited 2026 Feb 23]

Patients facing high OOP costs often discontinue therapy prematurely or dose less frequently to stretch prescriptions

Psychopathological characteristics of patients seeking for bariatric surgery, either affected or not by binge eating disorder following the criteria of the DSM IV TR and of the DSM 5

Oberg combines advanced weight loss medications with holistic treatments and health coaching to provide a custom, comprehensive weight loss program